Lei Zhang
zhlei07First product launched 10mo ago
- Public revenue
- Undisclosed
- No public revenue across products
100% full-depth creator dossier open: complete product portfolio, 12-month combined traffic & MRR curves, shipping cadence, and timeline events.
Traffic
Portfolio · Last 12 months
- Glunova Biotech
- +1 with <5K visits or no data
Products
| Product | Visits · Oct | Actions |
|---|---|---|
| Glunova BiotechEvidence-based resources for NAD+ Therapy, GLP-1 Medications (Semaglutide, Tirzepatide, Retatrutide), and Cellular Health Optimization | 13.3K | |
| inboxmcpMCPOSSYour email. Your agent. Your priorities. | <5K |
Timeline
Launches, marketing, revenue milestones, and pricing/plan/positioning changes across products
Nov 2 · 15d ago
Glunova Biotech Added product format: WebFeatures
—→web
Glunova Biotech Homepage tagline changed to “Evidence-based resources for NAD+ Therapy, GLP-1 Medications (Semaglutide, Tirzepatide, Retatrutide), and Cellular Health Optimization”Positioning
What We Do→Evidence-based resources for NAD+ Therapy, GLP-1 Medications (Semaglutide, Tirzepatide, Retatrutide), and Cellular Health Optimization
Oct 20 · 29d ago
inboxmcp launchedNew product
Jan 17 · 10mo ago
Glunova Biotech launchedNew product
Questions & evidence
- What products has Lei Zhang built?
- Lei Zhang tracks 2 standalone software products on EarlyLore (2 currently live), led by Glunova Biotech, inboxmcp.
- How much website traffic do Lei Zhang's products get?
- Across tracked standalone domains with web traffic estimates, Lei Zhang's portfolio reaches 13.3K combined monthly visits in each site's latest observed month. Coverage excludes shared third-party hosts and store listings.
Related indie founder research guides
Evaluate your own SaaS idea →